What's New on the Street? An Update on New Opioids, Psychoactive Drugs, and Synthetic Marijuana

Pamela A. Harris-Haman

Research output: Contribution to journalReview articlepeer-review

Abstract

Substance abuse is a widespread problem in the United States and worldwide. This use within the pregnant population is thought to reflect a pattern similar to the general population, with estimates of 10% to 15% of pregnant women experiencing substance abuse. Illicit substance use during pregnancy has increased substantially during the past decade in the United States. During the past decade, novel or atypical substances have emerged and become increasingly popular. Occurrences of toxicity and untoward fetal effects from designer drug use must be kept high on the watch list for all who practice in maternal-fetal, newborn, and emergency departments.

Original languageEnglish (US)
Pages (from-to)211-221
Number of pages11
JournalCritical care nursing clinics of North America
Volume36
Issue number2
DOIs
StatePublished - Jun 2024

Keywords

  • Neonatal withdrawal
  • Novel opioids
  • Novel psychoactive agents
  • Pregnancy
  • Synthetic marijuana

ASJC Scopus subject areas

  • Critical Care

Fingerprint

Dive into the research topics of 'What's New on the Street? An Update on New Opioids, Psychoactive Drugs, and Synthetic Marijuana'. Together they form a unique fingerprint.

Cite this